Basal Cell Carcinoma Clinical Trial

ClearlyDerm / Medical Dermatology / Clinical Trials / Basal Cell Carcinoma Clinical Trial

Basal Cell Carcinoma Clinical Trial

Patients diagnoised with basal cells carcinoma, also known as skin cancer , will be enrolled to evaluate new treatments for this skin cancer. Clinical trial participants will be monitored closely by medical professionals for the duration of the study. The goal of this basel cell carcinoma clinical trial is to develop better understanding of basel cell carcinoma and develop safe and effective therapies.

Study Snapshot

Duration

14 weeks to 16 weeks depending on study

Incentive

Subject compensation and travel assistance may be available. Study medication, study related exams, and lab tests will be provided at no cost.

Have questions about this clinical trial?

For general questions regarding our clinical trials, please contact our team at clinicaltrials@clearlyderm.com or fill out the contact form below.

    Frequently Asked Questions

    Click or Press on the Questions to See the Answers.

    What is a clinical trial?

    A clinical trial is a research study conducted with human volunteers to test the effectiveness and safety of new drugs, devices, or interventions. Our Clearlyderm clinical trials focus on skin conditions such as psoriasis, acne, rosacea, or atopic dermatitis (eczema).

    How can I join one of your clinical trials?

    To enroll in one of our clinical trials, contact our office. You will need to review and complete informed consent documents and complete screening procedures prior to participation.

    Are there risks from participating in a clinical trial?

    Like any medical treatment, potential risks exist. However, participants are informed of these risks prior to starting the clinical trials and receive monitoring and follow-up care throughout the trial duration if selected to participate.

    What is the purpose of this clinical trial

    This clinical trial is focused on finding efficient and less invasive ways to treat basal cell carcinoma. Basal cell carcinoma (BCC) is the most common type of skin cancer that develops due to sun exposure.

    Who is eligible to participate in this clinical trial?

    Patients who have recently been diagnosed with a basal cell carcinoma and have not yet received treatment.

    How long will this BCC clinical trial last?

    About 12-14 weeks

    Will I receive compensation for participating in this clinical trial?

    Yes, subjects enrolled in this clinical trial will receive compensation per attended visit.

    Schedule an appointment

    Looking to visit a dermatologist? Click the button below to schedule an appointment with our team of skin experts.

    Menu